Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer.

about

Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer.

Item

http://www.wikidata.org/entity/Q49239026

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Clinical rationale and safety ...... uscle-invasive bladder cancer.

@en

Clinical rationale and safety ...... uscle-invasive bladder cancer.

@nl

type

Item

label

Clinical rationale and safety ...... uscle-invasive bladder cancer.

@en

Clinical rationale and safety ...... uscle-invasive bladder cancer.

@nl

prefLabel

Clinical rationale and safety ...... uscle-invasive bladder cancer.

@en

Clinical rationale and safety ...... uscle-invasive bladder cancer.

@nl

P1476

Clinical rationale and safety ...... uscle-invasive bladder cancer.

@en

P2093

Andrzej Niewczas

http://www.w3.org/2001/XMLSchema#string

Piotr Radziszewski

http://www.w3.org/2001/XMLSchema#string

Piotr Zapała

http://www.w3.org/2001/XMLSchema#string

Sławomir Poletajew

http://www.w3.org/2001/XMLSchema#string

Łukasz Białek

http://www.w3.org/2001/XMLSchema#string

P2860

The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin

The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin.

The value of a second transurethral resection in evaluating patients with bladder tumours.

Surgeon has a major impact on long-term recurrence risk in patients with non-muscle invasive bladder cancer

Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy.

An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer.

Clinical value of transurethral second resection of bladder tumor: systematic review.

Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline.

Predictive factors for residual tumor and tumor upstaging on relook transurethral resection of bladder tumor in non-muscle invasive bladder cancer.

HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer--re-TURBT recurrence rates in a prospective, randomized study.

P2888

s12957-018-1310-0

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12957-018-1310-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bartosz Dybowski

P577

2018-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100404060

http://www.w3.org/2001/XMLSchema#string

P698

29334958

http://www.w3.org/2001/XMLSchema#string

P932

5769235

http://www.w3.org/2001/XMLSchema#string